Table 1.
Reported rates of HPV vaccination and clinician recommendation for HPV vaccination among teens 13–17 y old, by sex – National Immunization Survey-Teen, United States, 2013.
| Overall |
Girls |
Boys |
|||||
|---|---|---|---|---|---|---|---|
| n | % (95% CI) | n | % (95% CI) | n | % (95% CI) | p-value | |
| Number of HPV vaccine doses received | 18264 | 100.0 (———) | 8710 | 100.0 (———) | 9554 | 100.0 (———) | |
| 0 doses | 10089 | 54.3 (52.9–55.7) | 3723 | 42.7 (40.8–44.6) | 6366 | 65.4 (63.5–67.3) | <0.005 |
| 1–2 doses | 3474 | 20.2 (19.1–21.4) | 1656 | 19.7 (18.2–21.3) | 1818 | 20.7 (19.1–22.5) | 0.37 |
| ≥3 doses |
4701 |
25.5 (24.2–26.7) |
3331 |
37.6 (35.7–39.6) |
1370 |
13.9 (12.5–15.3) |
<0.005 |
| Received clinician recommendation to vaccinate teen for HPV | 18060 | 8611 | 9449 | ||||
| Yes | 10068 | 53.3 (51.9–54.7) | 5940 | 65.0 (63.1–67.0) | 4128 | 42.1 (40.2–44.0) | <0.005 |
| No/Don't know |
7992 |
46.7 (45.3–48.1) |
2671 |
35.0 (33.0–36.9) |
5321 |
57.9 (56.0–59.8) |
<0.005 |
| Age clinician recommended HPV vaccination be started* | 5939 | ||||||
| At or before 11–12 y old | – | – | 2779 | 45.0 (42.7–47.4) | – | – | – |
| At 13–16 y old | – | – | 2781 | 48.0 (45.6–50.3) | – | – | – |
| At 17–18 y old | – | – | 41 | 0.4 (0.3–0.6) | – | – | – |
| After 18 y old | – | – | NA | NA | – | – | – |
| No specific age discussed | – | – | 74 | 1.1 (0.8–1.5) | – | – | – |
| Don't know | – | – | 262 | 5.5 (4.5–6.7) | – | – | – |
NA = not available; estimates not reported due to small cell sizes. CI = confidence interval. HPV = human papillomavirus.
*
Restricted to respondents reporting a clinician recommendation for HPV vaccination. Data from parents of boys were not analyzed due to the timing of the recommendation for routine HPV vaccination of males.